Company filings, made visual.

Find a company. Follow its revenue through costs and profit.

Market

Find a company or ticker

Coverage includes separate ticker and security records; counts are not unique companies.

LivaNova PLC

LIVN

Filing: SEC 10-Q
Period: Three months ended March 31, 2026
Basis: Editorial filing; Read original SEC 10-Q ↗

Sankey diagram of LivaNova PLC. A complete text table follows the diagram.

LivaNova Medical Devices Revenue Flow

Medical devices and therapies convert clinical demand into healthcare revenue.

Swipe to explore

Source & review

Read original SEC 10-Q ↗

SEC accession: 0001639691-26-000035
Filed: Date not recorded
Reviewed: Date not recorded
Status: Individual filing review complete

How to read these figures

Labels and displayed flow values are reported filing values or exact disclosed subtotals.

Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.

LivaNova reports $362.258M of net revenue for the quarter.

View accessible tables

Financial categories · Three months ended March 31, 2026 · Millions of USD
Category	Stage	Value	Notes
LivaNova PLC revenue	1	$362M	$362.258M reported quarterly revenue
Medical devices and therapies	2	$362M	Reported net revenue

Financial flows · Millions of USD
From	To	Value
LivaNova PLC revenue	Medical devices and therapies	$362M